{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T19:28:20Z","timestamp":1783970900901,"version":"3.55.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"8-9","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011725","name":"Servier","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000555","name":"British Microcirculation Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000555","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002336","name":"Daiichi Sankyo Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007054","name":"Meso Scale Diagnostics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Cardiovascular Diseases"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.acvd.2019.04.002","type":"journal-article","created":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T21:16:38Z","timestamp":1558473398000},"page":"459-468","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Outcome associated with prescription of cardiac rehabilitation according to predicted risk after acute myocardial infarction: Insights from the FAST-MI registries"],"prefix":"10.1016","volume":"112","author":[{"given":"Etienne","family":"Puymirat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Bonaca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Christine","family":"Iliou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Tea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gr\u00e9gory","family":"Ducrocq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Douard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Labrunee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philoktimon","family":"Plastaras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Chevallereau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Taldir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Bataille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Ferri\u00e8res","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Schiele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tabassome","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Danchin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.acvd.2019.04.002_bib0205","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1177\/2047487312449597","volume":"21","author":"Piepoli","year":"2014","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.acvd.2019.04.002_bib0210","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","volume":"37","author":"Roffi","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2019.04.002_bib0215","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1093\/eurheartj\/ehs215","article-title":"ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation","volume":"33","author":"Steg","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2019.04.002_bib0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2015.10.044","article-title":"Exercise-based cardiac rehabilitation for coronary heart disease: cochrane systematic review and meta-analysis","volume":"67","author":"Anderson","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2019.04.002_bib0225","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.ahj.2015.08.001","article-title":"Effectiveness of cardiac rehabilitation among older patients after acute myocardial infarction","volume":"170","author":"Doll","year":"2015","journal-title":"Am Heart J"},{"key":"10.1016\/j.acvd.2019.04.002_bib0230","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.amjmed.2014.02.008","article-title":"Participation in cardiac rehabilitation, readmissions, and death after acute myocardial infarction","volume":"127","author":"Dunlay","year":"2014","journal-title":"Am J Med"},{"key":"10.1016\/j.acvd.2019.04.002_bib0235","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.ahj.2011.07.017","article-title":"Efficacy of exercise-based cardiac rehabilitation post-myocardial infarction: a systematic review and meta-analysis of randomized controlled trials","volume":"162","author":"Lawler","year":"2011","journal-title":"Am Heart J"},{"key":"10.1016\/j.acvd.2019.04.002_bib0240","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.acvd.2015.09.009","article-title":"Cardiac rehabilitation and 5-year mortality after acute coronary syndromes: The 2005 French FAST-MI study","volume":"109","author":"Pouche","year":"2016","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.acvd.2019.04.002_bib0245","doi-asserted-by":"crossref","first-page":"121","DOI":"10.5535\/arm.2017.41.1.121","article-title":"Quality of life and physical ability changes after hospital-based cardiac rehabilitation in patients with myocardial infarction","volume":"41","author":"Lee","year":"2017","journal-title":"Ann Rehabil Med"},{"key":"10.1016\/j.acvd.2019.04.002_bib0250","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/HCR.0b013e3181c8594b","article-title":"Cardiac rehabilitation, health behaviors, and body mass index post-myocardial infarction","volume":"30","author":"Zullo","year":"2010","journal-title":"J Cardiopulm Rehabil Prev"},{"key":"10.1016\/j.acvd.2019.04.002_bib0255","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.amjcard.2011.08.029","article-title":"Cardiovascular mortality and heart failure risk score for patients after ST-segment elevation acute myocardial infarction treated with primary percutaneous coronary intervention (Data from the Leiden MISSION! Infarct Registry)","volume":"109","author":"Antoni","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.acvd.2019.04.002_bib0260","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.amjcard.2013.02.049","article-title":"Development and validation of a cardiovascular risk assessment model in patients with established coronary artery disease","volume":"112","author":"Battes","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.acvd.2019.04.002_bib0265","doi-asserted-by":"crossref","first-page":"e000205","DOI":"10.1161\/JAHA.113.000205","article-title":"Simple integer risk score to determine prognosis of patients with hypertension and chronic stable coronary artery disease","volume":"2","author":"Bavry","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.acvd.2019.04.002_bib0270","first-page":"4","article-title":"Traditional risk factors versus biomarkers for prediction of secondary events in patients with stable coronary heart disease: from the heart and soul study","author":"Beatty","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.acvd.2019.04.002_bib0275","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1093\/eurheartj\/ehq326","article-title":"Underestimated and under-recognized: the late consequences of acute coronary syndrome (GRACE UK-Belgian Study)","volume":"31","author":"Fox","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2019.04.002_bib0280","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1093\/eurheartj\/ehs164","article-title":"Routinely available biomarkers improve prediction of long-term mortality in stable coronary artery disease: the Vienna and Ludwigshafen Coronary Artery Disease (VILCAD) risk score","volume":"33","author":"Goliasch","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2019.04.002_bib0285","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1161\/CIRCULATIONAHA.109.852749","article-title":"Cardiovascular risk prediction in patients with stable and unstable coronary heart disease","volume":"121","author":"Morrow","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2019.04.002_bib0290","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ijcard.2010.09.014","article-title":"A new risk score predicting 1- and 5-year mortality following acute myocardial infarction Soroka Acute Myocardial Infarction (SAMI) Project","volume":"154","author":"Plakht","year":"2012","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.acvd.2019.04.002_bib0295","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1016\/j.ijcard.2012.11.075","article-title":"Soroka acute myocardial infarction (SAMI) score predicting 10-year mortality following acute myocardial infarction","volume":"167","author":"Plakht","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.acvd.2019.04.002_bib0300","doi-asserted-by":"crossref","first-page":"e356","DOI":"10.1136\/bmj.e356","article-title":"25 year trends in first time hospitalisation for acute myocardial infarction, subsequent short and long term mortality, and the prognostic impact of sex and comorbidity: a Danish nationwide cohort study","volume":"344","author":"Schmidt","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.acvd.2019.04.002_bib0305","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.amjmed.2012.01.014","article-title":"An international model to predict recurrent cardiovascular disease","volume":"125","author":"Wilson","year":"2012","journal-title":"Am J Med"},{"key":"10.1016\/j.acvd.2019.04.002_bib0310","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ijcard.2007.03.122","article-title":"Potential demographic and baselines variables for risk stratification of high-risk post-myocardial infarction patients in the era of implantable cardioverter-defibrillator--a prognostic indicator","volume":"126","author":"Yap","year":"2008","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.acvd.2019.04.002_bib0315","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa0908610","article-title":"Population trends in the incidence and outcomes of acute myocardial infarction","volume":"362","author":"Yeh","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2019.04.002_bib0320","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1161\/CIRCULATIONAHA.115.019861","article-title":"Atherothrombotic risk stratification and the efficacy and safety of Vorapaxar in patients with stable ischemic heart disease and previous myocardial infarction","volume":"134","author":"Bohula","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2019.04.002_bib0325","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1056\/NEJMoa1200933","article-title":"Vorapaxar in the secondary prevention of atherothrombotic events","volume":"366","author":"Morrow","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2019.04.002_bib0330","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/S0140-6736(12)61269-0","article-title":"Vorapaxar for secondary prevention of thrombotic events for patients with previous myocardial infarction: a prespecified subgroup analysis of the TRA 2 degrees P-TIMI 50 trial","volume":"380","author":"Scirica","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.acvd.2019.04.002_bib0335","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jacc.2016.11.070","article-title":"Atherothrombotic Risk Stratification and Ezetimibe for Secondary Prevention","volume":"69","author":"Bohula","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2019.04.002_bib0340","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.atherosclerosis.2018.03.026","article-title":"External validation of the TIMI risk score for secondary cardiovascular events among patients with recent myocardial infarction","volume":"272","author":"Williams","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.acvd.2019.04.002_bib0345","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.acvd.2017.05.001","article-title":"French Registry on Acute ST-elevation and non-ST-elevation Myocardial Infarction 2015 (FAST-MI 2015). Design and baseline data","volume":"110","author":"Belle","year":"2017","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.acvd.2019.04.002_bib0350","first-page":"524","article-title":"The French registry of Acute ST elevation or non-ST-elevation Myocardial Infarction (FAST-MI): study design and baseline characteristics","volume":"100","author":"Cambou","year":"2007","journal-title":"Arch Mal Coeur Vaiss"},{"key":"10.1016\/j.acvd.2019.04.002_bib0355","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1136\/heartjnl-2012-301700","article-title":"French Registry on Acute ST-elevation and non ST-elevation Myocardial Infarction 2010 FAST-MI 2010","volume":"98","author":"Hanssen","year":"2012","journal-title":"Heart"},{"key":"10.1016\/j.acvd.2019.04.002_bib0360","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/HJR.0b013e328334f42d","article-title":"Cardiac rehabilitation in Europe: results from the European Cardiac Rehabilitation Inventory Survey","volume":"17","author":"Bjarnason-Wehrens","year":"2010","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"10.1016\/j.acvd.2019.04.002_bib0365","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/HCR.0000000000000126","article-title":"Predictors of enrollment in cardiac rehabilitation programs in Spain","volume":"35","author":"Chamosa","year":"2015","journal-title":"J Cardiopulm Rehabil Prev"},{"key":"10.1016\/j.acvd.2019.04.002_bib0370","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1177\/2047487312449591","article-title":"Use and effects of cardiac rehabilitation in patients with coronary heart disease: results from the EUROASPIRE III survey","volume":"20","author":"Kotseva","year":"2013","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.acvd.2019.04.002_bib0375","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1177\/2047487315569401","article-title":"EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries","volume":"23","author":"Kotseva","year":"2016","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.acvd.2019.04.002_bib0380","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/2047487316680692","article-title":"Cardiac rehabilitation following an acute coronary syndrome: Trends in referral, predictors and mortality outcome in a multicenter national registry between years 2006-2013: Report from the Working Group on Cardiac Rehabilitation, the Israeli Heart Society","volume":"24","author":"Chernomordik","year":"2017","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.acvd.2019.04.002_bib0385","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijcard.2018.01.096","article-title":"Referral for cardiac rehabilitation after acute myocardial infarction: Insights from nationwide AMIS Plus registry 2005-2017","volume":"261","author":"Hermann","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.acvd.2019.04.002_bib0390","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/j.jacc.2011.06.050","article-title":"Changes in myocardial infarction guideline adherence as a function of patient risk: an end to paradoxical care?","volume":"58","author":"Motivala","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2019.04.002_bib0395","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1177\/2047487316671181","article-title":"The prognostic effect of cardiac rehabilitation in the era of acute revascularisation and statin therapy: a systematic review and meta-analysis of randomized and non-randomized studies - The Cardiac Rehabilitation Outcome Study (CROS)","volume":"23","author":"Rauch","year":"2016","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.acvd.2019.04.002_bib0400","first-page":"764","article-title":"\u00c9volution temporelle du recours \u00e0 la r\u00e9adaptation cardiaque apr\u00e8s un infarctus du myocarde, France, 2010-2014","volume":"43","author":"Gabet","year":"2016","journal-title":"Bull Epid\u00e9miol Hebd"}],"container-title":["Archives of Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875213619300956?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875213619300956?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:45:15Z","timestamp":1761745515000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875213619300956"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":40,"journal-issue":{"issue":"8-9","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S1875213619300956"],"URL":"https:\/\/doi.org\/10.1016\/j.acvd.2019.04.002","relation":{},"ISSN":["1875-2136"],"issn-type":[{"value":"1875-2136","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcome associated with prescription of cardiac rehabilitation according to predicted risk after acute myocardial infarction: Insights from the FAST-MI registries","name":"articletitle","label":"Article Title"},{"value":"Archives of Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acvd.2019.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}